ALERT: Due to the inclement weather across much of the country, Medtronic deliveries are currently experiencing delays and there will be longer than normal hold times on the phone. Visit www.Diabetes.shop if you need to place an order, get a sensor or belt clip replacement, or check the status of your supply order. X
Country selector icon United States
Important Product Safety InformationAlert: Product and Recall Notices

InPen™
User Access
Program


Now, you can use an insulin pen without sacrificing data and decision support. The InPen system enhances how you manage MDI because it tracks your data in real time and offers personalized dosing recommendations.

Pay As Little As $35 Per Year, Per InPen.


  • Each InPen is reusable for one year.
  • Offer available to eligible patients with commercial insurance.
  • Terms and conditions apply.*

Fill out the form below
to see if you are eligible for this offer.


See below for terms and conditions.* Certain restrictions apply.

A member of our team will reach out to you about your eligibility. If you have questions please contact us at 888-882-8602.



∆ Data may not appear or be delayed in certain instances, including when there is no internet connection.

* Eligibility Requirements for InPen User Access Program:

Open to insured patients and patients with commercial prescription insurance and those who are not enrolled in any government-funded program that pays for prescription devices or treatments.

Excluded participants include patients enrolled in any federal, state, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD) or TRICARE® that provides coverage for InPen, or where prohibited by law.

Cash Discount Cards and other non-insurance plans are not valid as primary under this offer.

If at any time a patient becomes enrolled under any such federal, state, or government-funded healthcare program, he/she will no longer be able to use this program and must call (858) 522-0252 to stop participation.

Restrictions may apply.

Offer subject to change or discontinue without notice.

This is not health insurance.

Offer applies to a maximum of 1 prescribed InPen per Patient per benefit year.

Offer good only in the USA at participating pharmacies and cannot be redeemed at government-subsidized clinics.


Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

Important Safety Information: InPen™
The InPen™ is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.com.